136 related articles for article (PubMed ID: 7978067)
1. Expression of insulin-like growth factor I (IGF-I) in nevi and melanomas.
Fleming MG; Howe SF; Graf LH
Am J Dermatopathol; 1994 Aug; 16(4):383-91. PubMed ID: 7978067
[TBL] [Abstract][Full Text] [Related]
2. Expression of insulin-like growth factor-binding protein 2 in melanocytic lesions.
Wang H; Shen SS; Wang H; Diwan AH; Zhang W; Fuller GN; Prieto VG
J Cutan Pathol; 2003 Nov; 30(10):599-605. PubMed ID: 14744083
[TBL] [Abstract][Full Text] [Related]
3. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
Boyd AS; Shakhtour B; Shyr Y
J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
[TBL] [Abstract][Full Text] [Related]
4. Expression and distribution of transforming growth factor-alpha within melanocytic lesions.
Nanney LB; Coffey RJ; Ellis DL
J Invest Dermatol; 1994 Nov; 103(5):707-14. PubMed ID: 7963661
[TBL] [Abstract][Full Text] [Related]
5. Morphometric, DNA, and proliferating cell nuclear antigen measurements in benign melanocytic lesions and cutaneous malignant melanoma.
Björnhagen V; Bonfoco E; Brahme EM; Lindholm J; Auer G
Am J Dermatopathol; 1994 Dec; 16(6):615-23. PubMed ID: 7864299
[TBL] [Abstract][Full Text] [Related]
6. Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions.
Miracco C; Cevenini G; Franchi A; Luzi P; Cosci E; Mourmouras V; Monciatti I; Mannucci S; Biagioli M; Toscano M; Moretti D; Lio R; Massi D
Hum Pathol; 2010 Apr; 41(4):503-12. PubMed ID: 20004946
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 and D3 expression in melanocytic skin lesions.
Alekseenko A; Wojas-Pelc A; Lis GJ; Furgał-Borzych A; Surówka G; Litwin JA
Arch Dermatol Res; 2010 Sep; 302(7):545-50. PubMed ID: 20496072
[TBL] [Abstract][Full Text] [Related]
8. RT in situ PCR detection of MART-1 and TRP-2 mRNA in formalin-fixed, paraffin-embedded tissues of melanoma and nevi.
Itakura E; Huang RR; Wen DR; Paul E; Wünsch PH; Cochran AJ
Mod Pathol; 2008 Mar; 21(3):326-33. PubMed ID: 18204435
[TBL] [Abstract][Full Text] [Related]
9. TSLC1 expression discriminates cutaneous melanomas from dysplastic nevi.
You Y; Wang SH; Zhang JF; Zheng SY
Melanoma Res; 2012 Dec; 22(6):430-5. PubMed ID: 23047161
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.
Simonetti O; Lucarini G; Brancorsini D; Nita P; Bernardini ML; Biagini G; Offidani A
Cancer; 2002 Nov; 95(9):1963-70. PubMed ID: 12404291
[TBL] [Abstract][Full Text] [Related]
11. Preferentially Expressed Antigen in Melanoma Immunostaining in a Series of Melanocytic Neoplasms.
Googe PB; Flanigan KL; Miedema JR
Am J Dermatopathol; 2021 Nov; 43(11):794-800. PubMed ID: 33989214
[TBL] [Abstract][Full Text] [Related]
12. Protein expression of melanocyte growth factors (bFGF, SCF) and their receptors (FGFR-1, c-kit) in nevi and melanoma.
Giehl KA; Nägele U; Volkenandt M; Berking C
J Cutan Pathol; 2007 Jan; 34(1):7-14. PubMed ID: 17214848
[TBL] [Abstract][Full Text] [Related]
13. hTERT expression in melanocytic lesions: an immunohistochemical study on paraffin-embedded tissue.
Fullen DR; Zhu W; Thomas D; Su LD
J Cutan Pathol; 2005 Nov; 32(10):680-4. PubMed ID: 16293180
[TBL] [Abstract][Full Text] [Related]
14. Expression of the heat shock cognate protein HSP73 correlates with tumour thickness of primary melanomas and is enhanced in melanoma metastases.
Deichmann M; Polychronidis M; Benner A; Kleist C; Thome M; Kahle B; Helmke BM
Int J Oncol; 2004 Aug; 25(2):259-68. PubMed ID: 15254721
[TBL] [Abstract][Full Text] [Related]
15. Absence of estrogen receptors in dysplastic nevi and malignant melanoma.
Lecavalier MA; From L; Gaid N
J Am Acad Dermatol; 1990 Aug; 23(2 Pt 1):242-6. PubMed ID: 2212119
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of basic fibroblast growth factor (bFGF) in melanocytic lesions demonstrated by in situ hybridization. Implications for tumor progression.
Reed JA; McNutt NS; Albino AP
Am J Pathol; 1994 Feb; 144(2):329-36. PubMed ID: 8311116
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of VEGF, HIF1-a, and PlGF in malignant melanomas and dysplastic nevi.
Konstantina A; Lazaris AC; Ioannidis E; Liossi A; Aroni K
Melanoma Res; 2011 Oct; 21(5):389-94. PubMed ID: 21876459
[TBL] [Abstract][Full Text] [Related]
18. HDM2 protein overexpression, but not gene amplification, is related to tumorigenesis of cutaneous melanoma.
Polsky D; Bastian BC; Hazan C; Melzer K; Pack J; Houghton A; Busam K; Cordon-Cardo C; Osman I
Cancer Res; 2001 Oct; 61(20):7642-6. PubMed ID: 11606406
[TBL] [Abstract][Full Text] [Related]
19. Molecular Proof of a Clinical Concept: Expression of Estrogen Alpha-, Beta-Receptors and G Protein-Coupled Estrogen Receptor 1 (GPER) in Histologically Assessed Common Nevi, Dysplastic Nevi and Melanomas.
Spałkowska M; Dyduch G; Broniatowska E; Damiani G; Wojas-Pelc A
Medicina (Kaunas); 2021 Nov; 57(11):. PubMed ID: 34833446
[No Abstract] [Full Text] [Related]
20. Comprehensive analysis of 112 melanocytic skin lesions demonstrates microsatellite instability in melanomas and dysplastic nevi, but not in benign nevi.
Hussein MR; Sun M; Tuthill RJ; Roggero E; Monti JA; Sudilovsky EC; Wood GS; Sudilovsky O
J Cutan Pathol; 2001 Aug; 28(7):343-50. PubMed ID: 11437939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]